NM_006267.5:c.5941T>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_006267.5(RANBP2):​c.5941T>A​(p.Ser1981Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0122 in 1,611,950 control chromosomes in the GnomAD database, including 148 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 5 hom., cov: 32)
Exomes 𝑓: 0.013 ( 143 hom. )

Consequence

RANBP2
NM_006267.5 missense

Scores

1
4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 5.20

Publications

7 publications found
Variant links:
Genes affected
RANBP2 (HGNC:9848): (RAN binding protein 2) RAN is a small GTP-binding protein of the RAS superfamily that is associated with the nuclear membrane and is thought to control a variety of cellular functions through its interactions with other proteins. This gene encodes a very large RAN-binding protein that immunolocalizes to the nuclear pore complex. The protein is a giant scaffold and mosaic cyclophilin-related nucleoporin implicated in the Ran-GTPase cycle. The encoded protein directly interacts with the E2 enzyme UBC9 and strongly enhances SUMO1 transfer from UBC9 to the SUMO1 target SP100. These findings place sumoylation at the cytoplasmic filaments of the nuclear pore complex and suggest that, for some substrates, modification and nuclear import are linked events. This gene is partially duplicated in a gene cluster that lies in a hot spot for recombination on chromosome 2q. [provided by RefSeq, Jul 2008]
RANBP2 Gene-Disease associations (from GenCC):
  • familial acute necrotizing encephalopathy
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008125693).
BP6
Variant 2-108766480-T-A is Benign according to our data. Variant chr2-108766480-T-A is described in ClinVar as [Benign]. Clinvar id is 380579.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1234 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANBP2NM_006267.5 linkc.5941T>A p.Ser1981Thr missense_variant Exon 20 of 29 ENST00000283195.11 NP_006258.3 P49792

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANBP2ENST00000283195.11 linkc.5941T>A p.Ser1981Thr missense_variant Exon 20 of 29 1 NM_006267.5 ENSP00000283195.6 P49792

Frequencies

GnomAD3 genomes
AF:
0.00811
AC:
1234
AN:
152140
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0151
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0130
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00825
AC:
2044
AN:
247792
AF XY:
0.00832
show subpopulations
Gnomad AFR exome
AF:
0.00184
Gnomad AMR exome
AF:
0.00263
Gnomad ASJ exome
AF:
0.000100
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0147
Gnomad NFE exome
AF:
0.0139
Gnomad OTH exome
AF:
0.00679
GnomAD4 exome
AF:
0.0126
AC:
18409
AN:
1459692
Hom.:
143
Cov.:
33
AF XY:
0.0122
AC XY:
8827
AN XY:
726152
show subpopulations
African (AFR)
AF:
0.00165
AC:
55
AN:
33404
American (AMR)
AF:
0.00291
AC:
130
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000499
AC:
43
AN:
86164
European-Finnish (FIN)
AF:
0.0157
AC:
839
AN:
53420
Middle Eastern (MID)
AF:
0.000484
AC:
2
AN:
4136
European-Non Finnish (NFE)
AF:
0.0151
AC:
16740
AN:
1111818
Other (OTH)
AF:
0.00982
AC:
591
AN:
60206
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
1624
3248
4872
6496
8120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
628
1256
1884
2512
3140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00810
AC:
1234
AN:
152258
Hom.:
5
Cov.:
32
AF XY:
0.00764
AC XY:
569
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00286
AC:
119
AN:
41544
American (AMR)
AF:
0.00366
AC:
56
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.0151
AC:
160
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0130
AC:
883
AN:
68022
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00960
Hom.:
2
Bravo
AF:
0.00727
ESP6500AA
AF:
0.00268
AC:
11
ESP6500EA
AF:
0.0133
AC:
110
ExAC
AF:
0.00890
AC:
1069
EpiCase
AF:
0.0121
EpiControl
AF:
0.0112

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RANBP2: BP4, BS1, BS2 -

not specified Benign:1
Oct 11, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Familial acute necrotizing encephalopathy Benign:1
Nov 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
20
DANN
Benign
0.87
DEOGEN2
Benign
0.39
T
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.86
D
MetaRNN
Benign
0.0081
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
5.2
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.098
Sift
Benign
0.33
T
Sift4G
Pathogenic
0.0010
D
Polyphen
0.39
B
Vest4
0.18
MVP
0.58
MPC
0.38
ClinPred
0.018
T
GERP RS
5.8
Varity_R
0.18
gMVP
0.27
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61748150; hg19: chr2-109382936; COSMIC: COSV99032093; API